Evidence map›Paper›PMID 27091931›Full record

ArticleInfection and immunity2016

Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Samantha J Dando, Deepak S Ipe, Michael Batzloff, Matthew J Sullivan, David K Crossman, Michael Crowley, Emily Strong, Stephanie Kyan, Sophie Y Leclercq, Jenny A K Ekberg and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in cellular and infection microbiology · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Frontiers in cellular and infection microbiology · 2020
    Article
  10. Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome.Frontiers in cell and developmental biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Samantha J DandoInstitute for Glycomics, Griffith University, Gold Coast, Australia.
Deepak S IpeInstitute for Glycomics, Griffith University, Gold Coast, Australia.
Michael BatzloffInstitute for Glycomics, Griffith University, Gold Coast, Australia.
Matthew J SullivanSchool of Medical Science, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
David K CrossmanHeflin Center for Human Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Michael CrowleyHeflin Center for Human Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Emily StrongInstitute for Glycomics, Griffith University, Gold Coast, Australia.
Stephanie KyanInstitute for Glycomics, Griffith University, Gold Coast, Australia.
Sophie Y LeclercqSchool of Medical Science, and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Jenny A K EkbergSchool of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
James St JohnEskitis Institute for Drug Discovery, Griffith University, Brisbane, Australia.
Ifor R BeachamInstitute for Glycomics, Griffith University, Gold Coast, Australia i.beacham@griffith.edu.au g.ulett@griffith.edu.au.
Glen C UlettInstitute for Glycomics, Griffith University, Gold Coast, Australia i.beacham@griffith.edu.au g.ulett@griffith.edu.au.ORCID http://orcid.org/0000-0002-9638-8091
Griffith University · AUUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melioidosis, caused by the bacterium Burkholderia pseudomallei, is an often severe infection that regularly involves respiratory disease following inhalation exposure. Intranasal (i.n.) inoculation of mice represents an experimental approach used to study the contributions of bacterial capsular polysaccharide I (CPS I) to virulence during acute disease. We used aerosol delivery of B. pseudomallei to establish respiratory infection in mice and studied CPS I in the context of innate immune responses. CPS I improved B. pseudomallei survival in vivo and triggered multiple cytokine responses, neutrophil infiltration, and acute inflammatory histopathology in the spleen, liver, nasal-associated lymphoid tissue, and olfactory mucosa (OM). To further explore the role of the OM response to B. pseudomallei infection, we infected human olfactory ensheathing cells (OECs) in vitro and measured bacterial invasion and the cytokine responses induced following infection. Human OECs killed >90% of the B. pseudomallei in a CPS I-independent manner and exhibited an antibacterial cytokine response comprising granulocyte colony-stimulating factor, tumor necrosis factor alpha, and several regulatory cytokines. In-depth genome-wide transcriptomic profiling of the OEC response by RNA-Seq revealed a network of signaling pathways activated in OECs following infection involving a novel group of 378 genes that encode biological pathways controlling cellular movement, inflammation, immunological disease, and molecular transport. This represents the first antimicrobial program to be described in human OECs and establishes the extensive transcriptional defense network accessible in these cells. Collectively, these findings show a role for CPS I in B. pseudomallei survival in vivo following inhalation infection and the antibacterial signaling network that exists in human OM and OECs.

Indexed as

AnimalsBacterial CapsulesBacterial LoadBurkholderia pseudomalleiCells, CulturedComputational BiologyCytokinesCytotoxicity, ImmunologicDisease Models, AnimalFemaleGene Expression ProfilingHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansImmunity, InnateMelioidosisCytokinesVirulence Factors

Identifiers

PMID27091931
PMCPMC4936350
OpenAlexW2342295710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.